Daiichi Sankyo
Susie Campos is an accomplished professional with extensive experience in clinical operations and research, currently serving as Director of Business System and Operations Management-Clinical at Daiichi Sankyo US since August 2022. Previous roles at Novartis Institutes for BioMedical Research (NIBR) from October 2004 to August 2022 include Strategic Feasibility Expert and various director-level positions focused on clinical trial innovation and strategy. Early career roles at Wyeth and UMDNJ involved significant contributions to neuroscience research. Susie holds a Bachelor of Science in Biology from Rutgers University and a Clinical Research Certificate from Middlesex College.
This person is not in any teams
This person is not in any offices
Daiichi Sankyo
21 followers
Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Daiichi Sankyo Group and Ranbaxy Group. The Daiichi Sankyo Group segment comprises of Daiichi Sankyo Co., Ltd. and its subsidiaries. The Ranbaxy Group segment includes its core company, Ranbaxy Laboratories Ltd. Both group segments deal with business activities in prescription drugs and general pharmaceutical products. The company was founded on September 28, 2005 and is headquartered in Tokyo, Japan.